How is Artificial Intelligence Defining the Future of Drug Discovery?

Logo
Presented by

Anne Dhulesia & Stephen Roper, Partners - L.E.K. Consulting and guests from BenevolentAI, Charm Therapeutics & Goldman Sachs

About this talk

We hear about Artificial Intelligence (AI) all the time, but how is AI shaping the future of drug discovery? The use of AI within the pharma industry is set to have a major impact on driving forward the discovery of new drugs more quickly, efficiently and cheaply than traditional approaches. In this webinar, Anne and Stephen will be joined by Ivan Griffin of BenevolentAI, Laksh Aithani of Charm Therapeutics and Peter Kulka of Goldman Sachs and will discuss the opportunities and challenges associated with AI and will answer some pressing questions: • What is the promise of AI? • What are the critical considerations in drug development? • What are the key challenges to adoption? How to overcome them? • What does a successful AI strategy look like? Who should attend? • Leaders in Pharma and biotech companies • Leaders in AI companies in Life Sciences • R&D professionals • Pharma service providers • Business Development Managers • Anyone in private equity and venture capital
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (103)
Subscribers (7642)
We combine deep expertise with rigorous analysis to help business leaders navigate their markets, make the most of opportunities, and deliver better returns. Some of the world’s most sophisticated, innovative, and successful organisations choose us to help them maximise their potential. Visit us online at lek.com and follow us on Twitter, Facebook, LinkedIn and Instagram to meet more of our talented team and learn about the challenges we are helping clients overcome.